Options Derivatives News and Headlines
  • All Technology
  • AI
  • Autonomy
  • B2B Growth
  • Big Data
  • BioTech
  • ClimateTech
  • Consumer Tech
  • Crypto
  • Cybersecurity
  • DevOps
  • Digital Marketing
  • Ecommerce
  • EdTech
  • Enterprise
  • FinTech
  • GovTech
  • Hardware
  • HealthTech
  • HRTech
  • LegalTech
  • Nanotech
  • PropTech
  • Quantum
  • Robotics
  • SaaS
  • SpaceTech
AllNewsDealsSocialBlogsVideosPodcastsDigests
NewsDealsSocialBlogsVideosPodcasts
HomeOptions DerivativesNewsTraders Purchase Large Volume of Put Options on Centene (NYSE:CNC)
Traders Purchase Large Volume of Put Options on Centene (NYSE:CNC)
Options & Derivatives

Traders Purchase Large Volume of Put Options on Centene (NYSE:CNC)

•March 11, 2026
0
DefenseWorld/DW
DefenseWorld/DW•Mar 11, 2026

Companies Mentioned

Centene

Centene

CNC

JPMorgan Chase

JPMorgan Chase

JPM

Atlcap

Atlcap

MS^K

Barclays

Barclays

SBI Securities

SBI Securities

Why It Matters

The surge in put activity highlights growing market concern over Centene’s exposure to declining ACA enrollments and its ability to sustain profitability. Investors and analysts will watch how the company’s operational wins and debt redemptions offset this downside pressure.

Key Takeaways

  • •Put volume rose 67% above average
  • •Stock opened near $36, below 50‑day average
  • •Revenue beat expectations; EPS remained negative
  • •Analysts maintain Hold rating, target $42
  • •ACA enrollment decline pressures future earnings

Pulse Analysis

The recent spike in put‑option volume on Centene is a classic market signal that traders anticipate further downside. Buying 22,328 puts—well above the 13,355‑contract average—suggests investors are hedging against a potential price drop, especially as the stock trades below both its short‑term and long‑term moving averages. Such flow data often precedes heightened volatility, and when combined with sector‑wide concerns about Medicaid and ACA enrollment, it amplifies the bearish narrative.

Fundamentally, Centene delivered a mixed earnings report. Revenue climbed 21.9% year‑over‑year to $49.73 bn, comfortably beating consensus forecasts, yet the company posted a loss of $1.19 per share and a negative net margin, reflecting ongoing cost pressures and the impact of a steeper-than‑expected decline in Obamacare memberships. The balance sheet remains solid, with a debt‑to‑equity of 0.87 and liquidity ratios near 1.1, but the negative earnings per share and a PEG below 1 underscore the challenges of turning growth into profitability under current policy headwinds.

Analyst sentiment remains lukewarm. While Wells Fargo, JPMorgan, and Morgan Stanley have nudged price targets upward to the low‑$40s, the consensus rating stays at "Hold," indicating limited upside without a clear catalyst. Institutional investors have modestly increased positions, and recent operational wins—such as the Texas unit’s Foster Care Center—provide localized optimism. However, the broader trend of falling ACA enrollment and the heavy put flow suggest that any upside will require tangible improvements in margin performance or a shift in health‑policy dynamics.

Traders Purchase Large Volume of Put Options on Centene (NYSE:CNC)

Read Original Article
0

Comments

Want to join the conversation?

Loading comments...